Cellsearch(R) Circulating Tumor Cells, Breast

The Cellsearch(R) Circulating Tumor Cells, Breast test contains 1 test with 1 biomarker.

This test can detect the presence of Circulating Tumor Cells (CTC) in the peripheral blood of metastatic breast cancer, colorectal or prostate cancer in patients. A count of CTC of 5 or more in breast and prostate cancers and 3 CTC or more in colon cancer in 7.5 mL of blood is predictive of shorter progression free survival and overall survival. Physician can draw samples prior to a new line of therapy for baseline prediction. Physician can also draw samples at the first follow up visit for prediction of the therapy. The Veridex CellSearch® System is the only semi-automated system designed to standardize and optimize to measure CTC in peripheral blood. This test is also the only FDA approved kit for CTC detection.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: CellsearchR Circulating Tumor Cells Breast

Cellsearch(R) Circulating